Arcturus Therapeutics (ARCT) Stock Chart & Stock Price History $17.22 -0.68 (-3.80%) (As of 12/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Arcturus Therapeutics Stock Price Performance 5 Day Performance-6.11%1 Month Performance-3.37%3 Month Performance-9.65%6 Month Performance-58.43%Year-To-Date Performance-45.39%1 Year Performance-28.22% Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. ARCT Stock Chart for Thursday, December, 5, 2024 ARCT Chart by TradingView Arcturus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/04/2024$17.90$17.22-3.80%$18.31$17.17409,520 shs$466.49 million12/03/2024$18.64$17.90-3.97%$18.61$17.71423,427 shs$484.86 million12/02/2024$18.34$18.64+1.64%$18.97$18.23288,265 shs$504.96 million11/29/2024$17.51$18.34+4.74%$18.61$17.55201,909 shs$496.83 million11/28/2024$17.51$17.51$17.72$16.92231,533 shs$474.35 million11/27/2024$16.93$17.51+3.43%$17.72$16.92231,453 shs$474.35 million Get the Latest News and Ratings for ARCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/26/2024$17.58$16.93-3.70%$17.83$16.83254,873 shs$458.58 million11/25/2024$16.91$17.58+3.96%$18.31$17.32598,754 shs$476.19 million11/22/2024$17.06$16.91-0.88%$17.50$16.20523,236 shs$458.09 million11/21/2024$16.17$17.06+5.50%$17.30$15.50320,957 shs$462.16 million11/20/2024$18.06$16.17-10.47%$17.94$15.94448,627 shs$438.05 million11/19/2024$16.27$18.06+11.00%$18.09$16.18645,214 shs$489.25 million11/18/2024$16.02$16.27+1.56%$17.37$15.71939,605 shs$440.75 million11/15/2024$18.34$16.02-12.65%$18.00$14.931.20 million shs$433.98 million11/14/2024$19.18$18.34-4.38%$19.57$18.30402,614 shs$496.83 million11/13/2024$19.58$19.18-2.04%$20.01$19.17286,072 shs$519.59 million11/12/2024$20.37$19.58-3.88%$20.07$18.91534,709 shs$530.36 million11/11/2024$19.63$20.37+3.80%$21.61$20.12671,217 shs$548.56 million11/08/2024$18.74$19.63+4.75%$19.93$18.81386,604 shs$528.68 million11/07/2024$18.33$18.74+2.24%$19.28$18.54365,328 shs$504.67 million11/06/2024$18.35$18.33-0.11%$19.30$17.73860,520 shs$493.63 million11/05/2024$17.82$18.35+2.97%$18.40$17.26329,995 shs$494.17 million11/04/2024$18.00$17.82-1.00%$18.30$17.53220,922 shs$479.93 million Related Companies Recursion Pharmaceuticals Stock Price Chart Harmony Biosciences Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart Disc Medicine Stock Price Chart Xencor Stock Price Chart Galapagos Stock Price Chart Arvinas Stock Price Chart NewAmsterdam Pharma Stock Price Chart Evotec Stock Price Chart Immunocore Stock Price Chart Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARCT) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
